Pages that link to "Q36772901"
Jump to navigation
Jump to search
The following pages link to Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. (Q36772901):
Displaying 50 items.
- Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications (Q21129423) (← links)
- Immune responses at brain barriers and implications for brain development and neurological function in later life (Q21558388) (← links)
- Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy (Q26780502) (← links)
- Development, maintenance and disruption of the blood-brain barrier (Q26829668) (← links)
- P-Glycoprotein Transport of Neurotoxic Pesticides (Q28389145) (← links)
- Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders (Q29048615) (← links)
- Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders (Q29615839) (← links)
- New findings concerning vertebrate porin II--on the relevance of glycine motifs of type-1 VDAC. (Q30155135) (← links)
- Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. (Q33560284) (← links)
- Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration (Q33836942) (← links)
- An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats (Q33876743) (← links)
- Evidence of inflammatory system involvement in Parkinson's disease (Q33890818) (← links)
- Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography (Q34125735) (← links)
- 5-HT radioligands for human brain imaging with PET and SPECT (Q34192729) (← links)
- Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease (Q34224832) (← links)
- The blood-brain barrier in health and disease (Q34320420) (← links)
- Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment. (Q34353553) (← links)
- T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson's Disease (Q34392867) (← links)
- Treatment of multiple system atrophy using intravenous immunoglobulin (Q34463907) (← links)
- Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary. (Q35027962) (← links)
- Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy (Q35158609) (← links)
- Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia (Q35163198) (← links)
- Gene therapy for the nervous system: challenges and new strategies (Q35340196) (← links)
- Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease (Q35683102) (← links)
- Reproducibility of quantitative (R)-[11C]verapamil studies (Q35742284) (← links)
- Tissue-engineered microenvironment systems for modeling human vasculature (Q35748045) (← links)
- P-glycoprotein function at the blood-brain barrier: effects of age and gender (Q36382013) (← links)
- The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord (Q36590671) (← links)
- Advances in PET imaging of P-glycoprotein function at the blood-brain barrier (Q36638627) (← links)
- Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET. (Q36947632) (← links)
- PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo (Q36953090) (← links)
- Glutathione metabolism and Parkinson's disease (Q37078480) (← links)
- Neuroinflammation in Parkinson's disease (Q37079115) (← links)
- Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies. (Q37136665) (← links)
- Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease (Q37239081) (← links)
- Mechanisms of the penetration of blood-borne substances into the brain (Q37313443) (← links)
- Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis (Q37328854) (← links)
- Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain (Q37351380) (← links)
- Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications (Q37353400) (← links)
- Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat. (Q37550693) (← links)
- ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs (Q37575649) (← links)
- P-glycoprotein related drug interactions: clinical importance and a consideration of disease states (Q37732337) (← links)
- Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches (Q37777780) (← links)
- Neurovascular Coupling in Cognitive Impairment Associated With Diabetes Mellitus (Q37858357) (← links)
- ATP-Binding Cassette Transporters and Their Roles in Protecting the Brain (Q37868835) (← links)
- Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases (Q37890058) (← links)
- The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids (Q38007464) (← links)
- The blood-brain barrier: an engineering perspective. (Q38134725) (← links)
- Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease. (Q38241183) (← links)
- The prion hypothesis of Parkinson's disease (Q38418624) (← links)